A (continued)
- anti-myeloma monoclonal antibody-DM4 immunoconjugate BT-062
- anti-nerve growth factor monoclonal antibody JNJ-42160443
- anti-p53 T-cell receptor-transduced peripheral blood lymphocytes
- anti-PD-1 human monoclonal antibody MDX-1106
- anti-PD-1 monoclonal antibody CT-011
- anti-PD-L1 monoclonal antibody MDX-1105
- anti-PDGFR alpha monoclonal antibody IMC-3G3
- anti-PDGFR alpha monoclonal antibody MEDI-575
- anti-PKN3 siRNA Atu027
- anti-platelet-derived growth factor receptor alpha monoclonal antibody IMC-3G3
- anti-PLGF monoclonal antibody TB-403
- anti-PSCA fully human monoclonal antibody AGS-1C4D4
- anti-TGF-beta monoclonal antibody GC1008
- anti-thymocyte globulin
- anti-TRAIL R1-mAb
- anti-TRAIL R2 mAb HGS-ETR2
- anti-TweakR monoclonal antibody PDL192
- anti-VEGFR monoclonal antibody
- anti-VEGFR-1 monoclonal antibody IMC-18F1
- anti-VEGFR-2 fully human monoclonal antibody IMC-1121B
A (continued)
- antiandrogen
- antiandrogen therapy
- antiangiogenesis
- antiangiogenic
- antianxiety agent
- antiapoptotic
- antibacterial
- antibiotic
- antibody
- antibody therapy
- antibody-dependent cell-mediated cytotoxicity
- antibody-dependent cellular cytotoxicity
- anticachexia
- anticancer antibiotic
- anticancer therapy
- anticarcinogenic
- anticoagulant
- anticonvulsant
- antidepressant
- antidiarrheal